PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Sep 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-09-14

Reporting Person: Levinson Mitchell E. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-14	Common Stock	P	2500	$12.3575	Acquired	2500	Indirect
2017-09-14	Common Stock	P	445	$12.209	Acquired	445	Indirect
2017-09-14	Common Stock	P	445	$12.214	Acquired	445	Indirect
2017-09-14	Common Stock	P	445	$12.153	Acquired	445	Indirect